CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,796,000 | +38.2% | 314,083 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,641,000 | +69.5% | 314,083 | +677.6% | 0.00% | +200.0% |
| Q3 2017 | $3,328,000 | +43.0% | 40,391 | +62.4% | 0.00% | 0.0% |
| Q2 2017 | $2,328,000 | -18.8% | 24,866 | -20.2% | 0.00% | -50.0% |
| Q3 2015 | $2,866,000 | +23783.3% | 31,166 | +14066.4% | 0.00% | – |
| Q4 2014 | $12,000 | -89.2% | 220 | -91.0% | 0.00% | – |
| Q3 2014 | $111,000 | +9.9% | 2,443 | 0.0% | 0.00% | – |
| Q2 2014 | $101,000 | -40.9% | 2,443 | 0.0% | 0.00% | – |
| Q1 2014 | $171,000 | – | 2,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |